143 related articles for article (PubMed ID: 38662193)
1. Understanding Perspectives on Presbyopia and Use of Pilocarpine HCl 1.25% Twice Daily from Participants of the Phase 3 VIRGO Study.
Shafer BM; McGee SR; Ifantides C; Williamson BK; Kannarr S; Whyte J; Zhang Z; Yanke T; Schachter S
Ophthalmol Ther; 2024 Jun; 13(6):1723-1742. PubMed ID: 38662193
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study.
Kannarr S; El-Harazi SM; Moshirfar M; Lievens C; Kim JL; Peace JH; Safyan E; Liu H; Zheng S; Robinson MR
Am J Ophthalmol; 2023 Sep; 253():189-200. PubMed ID: 37149245
[TBL] [Abstract][Full Text] [Related]
3. Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2).
Lievens CW; Hom MM; McLaurin EB; Yuan J; Safyan E; Liu H
J Cataract Refract Surg; 2024 Jan; 50(1):57-63. PubMed ID: 37702453
[TBL] [Abstract][Full Text] [Related]
4. Impact of presbyopia treatment pilocarpine hydrochloride 1.25% on night-driving performance.
Waring GO; Brujic M; McGee S; Micheletti JM; Zhao C; Schachter S; Liu H; Safyan E
Clin Exp Optom; 2023 Dec; ():1-8. PubMed ID: 38044272
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials.
Holland E; Karpecki P; Fingeret M; Schaeffer J; Gupta P; Fram N; Smits G; Ignacio T; Lindstrom R
Clin Ther; 2024 Feb; 46(2):104-113. PubMed ID: 38216351
[TBL] [Abstract][Full Text] [Related]
6. Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies.
Price FW; Hom M; Moshirfar M; Evans D; Liu H; Penzner J; Robinson MR; Lee S; Wirta DL
Ophthalmol Sci; 2021 Dec; 1(4):100065. PubMed ID: 36246939
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.
Jackson MA; Giyanani J; Shabaik Y; Penzner J; Gore AV; Robinson MR; Waring GO
Ophthalmol Ther; 2022 Apr; 11(2):869-879. PubMed ID: 35235173
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.
Waring GO; Price FW; Wirta D; McCabe C; Moshirfar M; Guo Q; Gore A; Liu H; Safyan E; Robinson MR
JAMA Ophthalmol; 2022 Apr; 140(4):363-371. PubMed ID: 35238902
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the content validity of patient-reported outcome (PRO) instruments developed for use with individuals with phakic presbyopia, including the Near Activity Visual Questionnaire-presbyopia (NAVQ-P) and the near vision correction independence (NVCI) instrument.
Bentley S; Findley A; Chiva-Razavi S; Naujoks C; Patalano F; Johnson C; Arbuckle R; Wolffsohn JS
J Patient Rep Outcomes; 2021 Oct; 5(1):109. PubMed ID: 34689253
[TBL] [Abstract][Full Text] [Related]
10. Patient Perception and Self-Reported Outcomes with Presbyopia-Correcting Intraocular Lenses (PCIOLs): A Social Media Listening Study.
Zhu D; Dhariwal M; Zhang J; Smith A; Martin P
Ophthalmol Ther; 2024 Jan; 13(1):287-303. PubMed ID: 37948016
[TBL] [Abstract][Full Text] [Related]
11. Understanding the visual function symptoms and associated functional impacts of phakic presbyopia.
Bentley S; Findley A; Chiva-Razavi S; Naujoks C; Patalano F; Johnson C; Arbuckle R; Wolffsohn JS
J Patient Rep Outcomes; 2021 Nov; 5(1):114. PubMed ID: 34731344
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Experience of Living with and Managing Presbyopia.
Stokes J; Shirneshan E; Graham CA; Paulich M; Johnson N
Optom Vis Sci; 2022 Aug; 99(8):635-644. PubMed ID: 35678617
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Presbyopia, spectacles use and spectacle correction coverage for near vision among cloth weaving communities in Prakasam district in South India.
Marmamula S; Narsaiah S; Shekhar K; Khanna RC
Ophthalmic Physiol Opt; 2013 Sep; 33(5):597-603. PubMed ID: 23758169
[TBL] [Abstract][Full Text] [Related]
15. Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopia.
Shirneshan E; Coon CD; Johnson N; Stokes J; Wells T; Lundy JJ; Andrae DA; Evans CJ; Campbell J
J Patient Rep Outcomes; 2021 Dec; 5(1):125. PubMed ID: 34855038
[TBL] [Abstract][Full Text] [Related]
16. Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.
Zamora-de La Cruz D; Bartlett J; Gutierrez M; Ng SM
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012648. PubMed ID: 36705482
[TBL] [Abstract][Full Text] [Related]
17. Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.
Zamora-de La Cruz D; Zúñiga-Posselt K; Bartlett J; Gutierrez M; Abariga SA
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012648. PubMed ID: 32584432
[TBL] [Abstract][Full Text] [Related]
18. Psychometric evaluation of the near activity visual questionnaire presbyopia (NAVQ-P) and additional patient-reported outcome items.
Sims J; Sloesen B; Bentley S; Naujoks C; Arbuckle R; Chiva-Razavi S; Pascoe B; Stochl J; Findley A; O'Brien P; Wolffsohn JS
J Patient Rep Outcomes; 2024 Apr; 8(1):41. PubMed ID: 38592339
[TBL] [Abstract][Full Text] [Related]
19. Computer vision syndrome in presbyopia and beginning presbyopia: effects of spectacle lens type.
Jaschinski W; König M; Mekontso TM; Ohlendorf A; Welscher M
Clin Exp Optom; 2015 May; 98(3):228-33. PubMed ID: 25963113
[TBL] [Abstract][Full Text] [Related]
20. Patients' attitudes and beliefs to presbyopia and its correction.
Hutchins B; Huntjens B
J Optom; 2021; 14(2):127-132. PubMed ID: 32241701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
